Johnson & Johnson Q3 net earnings fall 96% to $210 million; sales rise 6% to $25.4 billion
Bitget2026/10/13 10:22- Johnson & Johnson posted Q3 2026 net earnings of USD 210 million, swinging from profit a year earlier.
- Reported sales rose 6% to USD 25.4 billion versus Q3 2025.
- Innovative Medicine net sales climbed 8% to USD 16.76 billion, while MedTech net sales increased to USD 8.64 billion.
- CEO Joaquín Duato cited “accelerating momentum” and highlighted OTTAVA progress and positive Phase 3 multiple myeloma results.
- 2026 reported sales guidance increased to USD 101.0 billion–USD 101.4 billion, with adjusted EPS guidance lifted to USD 11.05–USD 11.15.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Circle issues 500 million USDC on the Solana network

Cardano vs Solana: Analysts and ADA Holders Clash Over Adoption

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share
Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.

